Update on the use of nonhuman primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells

Human Gene Therapy

Volumn 12, Issue 6, 2001, Pages 607-617

  Donahue, R E ^a   Dunbar, C E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; CELL POPULATION; GENE THERAPY; GENE TRANSFER; HEMATOPOIETIC CELL; LENTIVIRINAE; LYMPHOCYTE; NONHUMAN; PRIMATE; RETROVIRUS; REVIEW; SAFETY;

ANIMALS; DRUG EVALUATION, PRECLINICAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; MACACA; MODELS, ANIMAL; T-LYMPHOCYTES;

ADENOVIRIDAE; ANIMALIA; LENTIVIRUS; MURINAE; PRIMATES; UNIDENTIFIED RETROVIRUS;

EID: 0035831610     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401300057289     Document Type: Review

References (103)

1. Behavior of hematopoietic stem cells in a large animal
2. Evidence that hematopoiesis may be a stochastic process in vivo
3. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G
4. In vivo selection of retrovirally transduced hematopoietic stem cells
5. Lentiviral mediated hematopoietic stem cell gene transfer of common gamma chain cytokine receptor in rhesus macaques
6. + cells
7. In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells
8. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates
9. Differential engraftment of genetically modified CD34(+) and CD34(-) hematopoietic cell subsets in lethally irradiated baboons
10. Gene therapy: Intracellular immunization
11. Myelosuppressive conditioning improves autologous engraftment of genetically marked hematopoietic repopulating cells in dogs
12. Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors
13. + marrow cells engraft lethally irradiated baboons
14. A newly discovered class of human hematopoietic cells with SCID- repopulating activity
15. T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years
16. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
17. Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells
18. Survival and retrovirus infection of murine hematopoietic stem cells in vitro: Effects of 5-FU and method of infection
19. Long term expression of a murine adenosine deaminase (ADA) gene in rhesus hematopoietic cells of multiple lineages following retroviral mediated gene transfer into CD34+ bone marrow cells
20. Bone marrow collected 14 days after in vivo administration of granulocyte colony stimulating factor (G-CSF) and stem cell factor (SCF) to mice has 10 fold more repopulating ability than untreated bone marrow
21. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
22. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients
23. Gene marking
24. Gene transfer by adenovectors
25. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells
26. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes
27. Efficient in vivo marking of primary CD4+ T lymphocytes in non-human primates using a gibbon ape leukemia virus-derived retroviral vector
28. Transplantation of transduced nonhuman primate CD34+ cells using a gibbon ape leukemia virus vector: Restricted expression of the gibbon ape leukemia virus receptor to a subset of CD34+ cells
29. Molecular evolution and species specificity of interleukin-3
30. Stable transduction of quiescent CD34+CD38- human hematopoietic cells by HIV-1-based lentiviral vectors
31. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
32. Green fluorescent protein as a marker for gene expression
33. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo
34. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells
35. Improved green fluorescent protein by molecular evolution using DNA shuffling
36. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer
37. + cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or non mobilized with granulocyte colony-stimulating factor and/or stem cell factor
38. Transplantation and gene transfer of the human glucocerebrosidase gene into immunoselected primate CD34+Thy-1+ cells
39. Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes
40. High levels of lymphoid expression of enhanced green fluorescent protein in nonhuman primates transplanted with cytokine-mobilized peripheral blood CD34(+) cells
41. A third-generation lentivirus vector with a conditional packaging system
42. Gene transfer to hematopoietic stem cells: Implications for gene therapy of human disease
43. Retrovirally-marked CD34-enriched peripheral blood and bone marrow and cells contribute to long-term engraftment after au-tologous transplantation
44. Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primedin vivo with stem cell factor and granulocyte colony-stimulating factor
45. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics
46. Canine hemophilia B resulting from a point mutation with unusual consequences
47. Lentivirus vector mobilization and spread by human immunodeficiency virus
48. Animal models of AIDS
49. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species
50. The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit
51. Green fluorescent protein retroviral vectors: Low titer and high recombination frequency suggest a selective disadvantage
52. In vivo marking of rhesus monkey lymphocytes by adeno-associated viral vectors: Direct comparison with retroviral vectors
53. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells
54. Versatile retroviral vectors for potential use in gene therapy
55. Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model
56. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
57. Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning
58. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
59. Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer
60. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters
61. Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein
62. Gene transfer into marrow repopulating cells: Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons
63. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, Flt-3 ligand, and megakaryocyte growth and development factor
64. Many multi-potential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates
65. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells
66. Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hematopoietic progenitors
67. The rhesus macaque as an animal model for hemophilia B gene therapy
68. Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity
69. Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: Implications for gene therapy
70. T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia
71. Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin
72. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
73. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
74. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
75. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors
76. Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments
77. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
78. Efficient transfer, integration and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
79. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction
80. Identification of human and mouse hematopoietic stem cell populations expressing high levels of mRNA encoding retrovirus receptors
81. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell
82. Sustained high-level reconstitution of the hematopoietic system by preselected hematopoeitic cells expressing a transduced cell-surface antigen
83. Gene therapy for the hemoglobin disorders: Past, present, and future
84. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo
85. Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells
86. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts
87. Using GFP to see the light
88. An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer
89. Transduction of non-dividing cells using pseudotyped defective high-titer HIV type 1 particles
90. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients
91. Gene therapist, heal thyself
92. Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonabla-tive conditioning
93. Extension primer tag selection followed by solid-phase ligation-mediated (LM) PCR represents a powerful tool for the clonality analysis of transduced hematopoietic cell clones
94. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice
95. The four classes of endogenous murine leukemia virus: Structural relationships and potential for recombination
96. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability
97. The rhesus monkey as a preclinical model for bone marrow transplantation
98. Gene transfer into hematopoietic stem cells of nonhuman primates
99. A factor IX-deficient mouse model for hemophilia B gene therapy
100. Prolonged high-level detection of retrovirally-marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods
101. Long-term in vivo expression of the human glucocerebrosidase gene in nonhuman primates using retroviral supernatant transduction protocols
102. Growth-supporting activities of fibronectin on hematopoietic stem/progenitor cellsin vitro andin vivo: Structural requirements for fibronectin activities of CS1 and cell-binding domains
103. Cytokine manipulation of primitive human hematopoietic cell self-renewal